Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling.

Oncotarget - 28 Jun 2016

Davis Jason E, Xie Xiayang, Guo Jianhui, Huang Wei, Chu Wen-Ming, Huang Shuang, Teng Yong, Wu Guangyu

Abstract excerpt

ADP-ribosylation factor 1 (ARF1) is a crucial regulator in vesicle-mediated membrane trafficking and involved in the activation of signaling molecules. However, virtually nothing is known about its function in prostate cancer. Here we have demonstrated that ARF1 expression is significantly elevated in prostate cancer cells and human tissues and that the expression levels of ARF1 correlate with the activation of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ADP-Ribosylation Factor 1
Share to Butadienes
Share to Carcinogenesis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Flavonoids

Share to MAP Kinase Kinase 4

Share to Mice, SCID

Share to Nitriles

Share to p38 Mitogen-Activated Protein Kinases

Source

Open in PubMed Open full text

Identifiers

PMID: 27213581
DOI: 10.18632/oncotarget.9405
PMCID: PMC5129974

Genes

ARF1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling.PMID 27213581Read ↗

Reciprocal regulation between RACGAP1 and AR contributes to endocrine therapy resistance in prostate cancerSemantic proximity Read ↗

ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancerSemantic proximity Read ↗

Hormone-Dependent Prostate Cancers are Dependent on Rac Signaling for Growth and SurvivalSemantic proximity Read ↗

Non-Canonical Functions of the ARF Tumor Suppressor in Development and TumorigenesisSemantic proximity Read ↗

ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancerSemantic proximity Read ↗

Clinical relevance of ARF/ARL family genes and oncogenic function of ARL4C in endometrial cancerSemantic proximity Read ↗

G Proteins in Cancer: The Prostate Cancer ParadigmSemantic proximity Read ↗

Arf family GTPases: roles in membrane traffic and microtubule dynamicsSemantic proximity Read ↗

Suppression of tumor suppressors in prostate cancer: the emergence of a novel oncogenic pathway.Semantic proximity Read ↗

Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations.Semantic proximity Read ↗

Receptor for Activated C Kinase 1 (RACK1) and Src Regulate the Tyrosine Phosphorylation and Function of the Androgen ReceptorSemantic proximity Read ↗

Oleic acid promotes prostate cancer malignant phenotype via the G protein-coupled receptor FFA1/GPR40.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.